Dr. Ritvik Prakash Mehta, MD

Dr. Mehta practices at EGL Ambulatory Surgery Center in La Jolla, California.

Dr. Mehta's NPI, 1245393586, was assigned on December 18, 2006. Dr. Mehta graduated from UC San Diego School of Medicine in 2001. Dr. Mehta's California license number on file is A93336.

Dr. Mehta's primary practice is EGL Ambulatory Surgery Center, at 9834 Genesee Ave, La Jolla, CA 92037. The practice phone is (858) 453-3133.

Dr. Mehta's primary practice is EGL Ambulatory Surgery Center in La Jolla, California. Dr. Mehta is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is California Head & Neck Specialists. Dmand AI also links Dr. Mehta to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Dr. Mehta is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Mehta's licenses on file in 2 states: California and New Hampshire.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Mehta treats.

CMS data shows 509 Medicare services from Dr. Mehta across 11 procedure codes in 2024, for 231 Medicare patients. Medicare paid $39,470 for them. Every service was in an office.

CMS counts 231 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 104 patients. 74% of them have high cholesterol, and 69% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 69, with 55% women.

In 2024, Dr. Mehta wrote 144 Medicare Part D claims for 53 patients. 95% of them were for generic drugs. CMS names the drug for 86 of them, across 4 drugs with 11 or more claims each, at $385 in total drug cost. In 2023, CMS named 206 claims across 5 drugs.

Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Mehta, published from 2015 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Iontophoresis, Lidocaine and Middle Ear Ventilation. Dr. Mehta has published most often in Arch Otolaryngol Head Neck Surg. Dr. Mehta's most frequent co-authors are Daniel G. Deschler, MD, John P. Gavin, MD and Susannah Eldridge Hills, MD.

Dmand AI links Dr. Mehta to 5 clinical trials. Conditions studied include Endolymphatic Hydrops, Hearing Loss, Unilateral and Hearing Loss, Conductive. Otonomy, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Mehta that name 2 trials.

CMS Open Payments shows 103 general payments to Dr. Mehta from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 40% of the total. Smith & Nephew, Inc. paid the most, $10,010. It also lists 12 research payments totaling $39,527 in 2017, naming 2 clinical trials.

Dr. Mehta graduated from UC San Diego School of Medicine in 2001.

Dr. Mehta is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.